INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5262.73M
Enterprise Value 3233.02M
Trailing P/E N/A
Forward P/E 1-2.76
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.27
Price/Book (mrq)3.37
Enterprise Value/Revenue 37.33
Enterprise Value/EBITDA 6-2.74

Trading Information

Stock Price History

Beta (3Y Monthly) 2.56
52-Week Change 3-34.57%
S&P500 52-Week Change 36.34%
52 Week High 36.3000
52 Week Low 32.1500
50-Day Moving Average 32.7246
200-Day Moving Average 33.6523

Share Statistics

Avg Vol (3 month) 31.06M
Avg Vol (10 day) 3893k
Shares Outstanding 598.03M
Float 94.31M
% Held by Insiders 16.28%
% Held by Institutions 137.49%
Shares Short (Jun 28, 2019) 411.74M
Short Ratio (Jun 28, 2019) 47.7
Short % of Float (Jun 28, 2019) 412.75%
Short % of Shares Outstanding (Jun 28, 2019) 411.97%
Shares Short (prior month May 31, 2019) 413.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 24/1
Last Split Date 3Jun 6, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -295.25%
Operating Margin (ttm)-282.80%

Management Effectiveness

Return on Assets (ttm)-30.79%
Return on Equity (ttm)-96.78%

Income Statement

Revenue (ttm)31.78M
Revenue Per Share (ttm)0.34
Quarterly Revenue Growth (yoy)85.00%
Gross Profit (ttm)-64.78M
EBITDA -84.99M
Net Income Avi to Common (ttm)-93.84M
Diluted EPS (ttm)-0.9970
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)128M
Total Cash Per Share (mrq)1.31
Total Debt (mrq)84.44M
Total Debt/Equity (mrq)104.29
Current Ratio (mrq)4.92
Book Value Per Share (mrq)0.80

Cash Flow Statement

Operating Cash Flow (ttm)-93.43M
Levered Free Cash Flow (ttm)-64.42M